This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.
—Ackart et al, in the January Archives (1983;143:30-31), presented impressive data on 1,428 outpatient fiberoptic bronchoscopies (FOB), documenting the safety of this diagnostic procedure when using topical anesthesia in selected patients whose conditions do not require transbronchial biopsies or fluoroscopic control. At about the same time that the first 318 of these patients were reviewed at Portsmouth, Va,1 I presented my own experience with 380 patients examined in an outpatient setting.2 My own patients differed from the Portsmouth patients in that parenteral premedication was always given (including atropine sulfate, pentobarbitol sodium, and/or morphine sulfate) and that 41 transbronchial biopsies were performed. This experience, together with our subsequent 500 + bronchoscopies performed without significant morbidity (unpublished data), establishes the low morbidity of the procedure, irrespective of the use of premedication and the performance of transbronchial biopsy. Pertinent data from my original study is briefly reviewed herein, since
Aelony Y. Outpatient Fiberoptic Bronchoscopies. Arch Intern Med. 1983;143(9):1837. doi:10.1001/archinte.1983.00350090215053
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: